Literature DB >> 35762440

[Research advances in the clinical genetics of leukodystrophy in children].

Zhe-Lan Huang1, Wen-Hao Zhou1.   

Abstract

Leukodystrophy (LD) is a group of genetic heterogeneous diseases characterized by primary abnormalities in glial cells and myelin sheath, and it is a common nervous system disease in children and has significant genotype-phenotype correlation. In recent years, the improvement in high-throughput sequencing has changed the diagnostic and therapeutic mode of LD, and elaborative phenotype analysis, such as the collection of natural history and multimodal neuroimaging evaluation during development, also provides important information for subsequent genetic diagnosis. This article reviews LD from the perspective of clinical genetics, in order to improve the awareness of this disease among pediatricians in China.

Entities:  

Keywords:  Child; Clinical genetics; Gene; Leukodystrophy

Mesh:

Year:  2022        PMID: 35762440      PMCID: PMC9250391          DOI: 10.7499/j.issn.1008-8830.2202020

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  41 in total

Review 1.  Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.

Authors:  Ken Inoue
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 2.  Leukodystrophies and genetic leukoencephalopathies in children.

Authors:  C Sarret
Journal:  Rev Neurol (Paris)       Date:  2019-06-04       Impact factor: 2.607

Review 3.  Childhood leukodystrophies: A literature review of updates on new definitions, classification, diagnostic approach and management.

Authors:  Mahmoud Reza Ashrafi; Ali Reza Tavasoli
Journal:  Brain Dev       Date:  2017-01-20       Impact factor: 1.961

4.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing.

Authors:  Murim Choi; Ute I Scholl; Weizhen Ji; Tiewen Liu; Irina R Tikhonova; Paul Zumbo; Ahmet Nayir; Ayşin Bakkaloğlu; Seza Ozen; Sami Sanjad; Carol Nelson-Williams; Anita Farhi; Shrikant Mane; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-27       Impact factor: 11.205

Review 5.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

6.  Drug discovery for X-linked adrenoleukodystrophy: An unbiased screen for compounds that lower very long-chain fatty acids.

Authors:  Ann B Moser; Yanqiu Liu; Xiaohai Shi; Ulrike Schrifl; Shandi Hiebler; Ali Fatemi; Nancy E Braverman; Steven J Steinberg; Paul A Watkins
Journal:  J Cell Biochem       Date:  2021-05-30       Impact factor: 4.480

7.  Genome sequencing identifies three molecular diagnoses including a mosaic variant in the COL2A1 gene in an individual with Pol III-related leukodystrophy and Feingold syndrome.

Authors:  Kayla J Muirhead; Amanda R Clause; Zinayida Schlachetzki; Holly Dubbs; Denise L Perry; R Tanner Hagelstrom; Ryan J Taft; Adeline Vanderver
Journal:  Cold Spring Harb Mol Case Stud       Date:  2021-12-09

8.  Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review.

Authors:  Cecilie Videbæk; Jette Stokholm; Henrik Sengeløv; Lone U Fjeldborg; Vibeke Andrée Larsen; Christian Krarup; Jørgen E Nielsen; Sabine Grønborg
Journal:  JIMD Rep       Date:  2021-05-06

Review 9.  Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches.

Authors:  Alisa A Shaimardanova; Daria S Chulpanova; Valeriya V Solovyeva; Aysilu I Mullagulova; Kristina V Kitaeva; Cinzia Allegrucci; Albert A Rizvanov
Journal:  Front Med (Lausanne)       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.